Clinical Trial Update: Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of a personalized autologous cancer vaccine for prostate cancer reports safety and early effectiveness results; results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Autologous cellular vaccine

Snippet

Sponsor: Rockefeller University | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-01-08